CAMP Q2 2021 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$80M-0.7% YoY

Gross Profit

$32M40.7% margin

Operating Income

-$1M-1.5% margin

Net Income

-$2M-2.4% margin

EPS (Diluted)

$-0.06

QoQ Revenue Growth

-2.8%

Cash Flow

Operating Cash Flow

$78,000

Free Cash Flow

-$3M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$421M

Total Liabilities

$325M

Stockholders' Equity

$96M

Cash & Equivalents

$96M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$80M	$80M	-0.7%
Gross Profit	$32M	$31M	+4.5%
Operating Income	-$1M	-$10M	+87.6%
Net Income	-$2M	-$14M	+86.5%

Revenue Segments

Product

$52M65%

Application Subscriptions And Other Services

$28M35%

Geographic Segments

UNITED STATES

$51M64%

E M E A

$14M18%

South America

$7M8%

Asia Pacific

$5M7%

All Other

$2M3%